Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

Christie Orschell, Bartley Halstead, Susan Rice, Jon Mcmahel, Edward Srour, Kenneth Cornetta

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

To investigate the mechanisms behind the leukaemic expansion of chronic myelogenous leukaemia (CML), we examined the cell cycle status and activation kinetics of purified subpopulations of CD34+ cells from normal and CML bone marrow (BM). Propidium iodide staining was used to assess cell cycle status of fresh cells or those stimulated with cytokines. Although the cell cycle status of fresh low-density cells from CML and normal BM was similar, a larger percentage of CIVIL CD34+ cells were cycling than those from normal BM. The HLA-DR-compartment of CML CD34+ cells, a fraction enriched for normal, non-leukaemic progenitors, contained a higher percentage of quiescent cells than the CD34+ HLA-DR+ fraction. When the activation of CD34+ cells was examined in response to SCF or IL-3 alone, or SCF+IL-3+IL-6, CML CD34+ cells exited G0/G1 more rapidly than normal CD34+ cells. Interestingly, although normal BM CD34+ cells failed to cycle in response to IL-6 alone, or in the absence of exogenous cytokines, 30% of CML cells cycled under these conditions. No differences in the degree of apoptosis were documented among CML and normal CD34+ cells in these cultures. These data suggest that enhanced cell cycle activation of CML CD34+ cells, by either autocrine stimuli or via enhanced sensitivity to exogenous stimuli, may be partially responsible for the pronounced cellular expansion characteristic of CML.

Original languageEnglish
Pages (from-to)759-767
Number of pages9
JournalBritish Journal of Haematology
Volume102
Issue number3
DOIs
StatePublished - 1998

Fingerprint

Cell Cycle Resting Phase
G1 Phase
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cell Cycle
Bone Marrow
Interleukin-3
HLA-DR Antigens
Interleukin-6
Cytokines
Propidium
Bone Marrow Cells
Cell Culture Techniques
Cell Count
Apoptosis
Staining and Labeling

Keywords

  • Apoptosis
  • Cell cycle
  • Chronic myelogenous leukaemia
  • Cytokines
  • Proliferation

ASJC Scopus subject areas

  • Hematology

Cite this

Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells. / Orschell, Christie; Halstead, Bartley; Rice, Susan; Mcmahel, Jon; Srour, Edward; Cornetta, Kenneth.

In: British Journal of Haematology, Vol. 102, No. 3, 1998, p. 759-767.

Research output: Contribution to journalArticle

@article{c60b1e2f4e114880b1f443ec97e5433e,
title = "Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells",
abstract = "To investigate the mechanisms behind the leukaemic expansion of chronic myelogenous leukaemia (CML), we examined the cell cycle status and activation kinetics of purified subpopulations of CD34+ cells from normal and CML bone marrow (BM). Propidium iodide staining was used to assess cell cycle status of fresh cells or those stimulated with cytokines. Although the cell cycle status of fresh low-density cells from CML and normal BM was similar, a larger percentage of CIVIL CD34+ cells were cycling than those from normal BM. The HLA-DR-compartment of CML CD34+ cells, a fraction enriched for normal, non-leukaemic progenitors, contained a higher percentage of quiescent cells than the CD34+ HLA-DR+ fraction. When the activation of CD34+ cells was examined in response to SCF or IL-3 alone, or SCF+IL-3+IL-6, CML CD34+ cells exited G0/G1 more rapidly than normal CD34+ cells. Interestingly, although normal BM CD34+ cells failed to cycle in response to IL-6 alone, or in the absence of exogenous cytokines, 30{\%} of CML cells cycled under these conditions. No differences in the degree of apoptosis were documented among CML and normal CD34+ cells in these cultures. These data suggest that enhanced cell cycle activation of CML CD34+ cells, by either autocrine stimuli or via enhanced sensitivity to exogenous stimuli, may be partially responsible for the pronounced cellular expansion characteristic of CML.",
keywords = "Apoptosis, Cell cycle, Chronic myelogenous leukaemia, Cytokines, Proliferation",
author = "Christie Orschell and Bartley Halstead and Susan Rice and Jon Mcmahel and Edward Srour and Kenneth Cornetta",
year = "1998",
doi = "10.1046/j.1365-2141.1998.00839.x",
language = "English",
volume = "102",
pages = "759--767",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

AU - Orschell, Christie

AU - Halstead, Bartley

AU - Rice, Susan

AU - Mcmahel, Jon

AU - Srour, Edward

AU - Cornetta, Kenneth

PY - 1998

Y1 - 1998

N2 - To investigate the mechanisms behind the leukaemic expansion of chronic myelogenous leukaemia (CML), we examined the cell cycle status and activation kinetics of purified subpopulations of CD34+ cells from normal and CML bone marrow (BM). Propidium iodide staining was used to assess cell cycle status of fresh cells or those stimulated with cytokines. Although the cell cycle status of fresh low-density cells from CML and normal BM was similar, a larger percentage of CIVIL CD34+ cells were cycling than those from normal BM. The HLA-DR-compartment of CML CD34+ cells, a fraction enriched for normal, non-leukaemic progenitors, contained a higher percentage of quiescent cells than the CD34+ HLA-DR+ fraction. When the activation of CD34+ cells was examined in response to SCF or IL-3 alone, or SCF+IL-3+IL-6, CML CD34+ cells exited G0/G1 more rapidly than normal CD34+ cells. Interestingly, although normal BM CD34+ cells failed to cycle in response to IL-6 alone, or in the absence of exogenous cytokines, 30% of CML cells cycled under these conditions. No differences in the degree of apoptosis were documented among CML and normal CD34+ cells in these cultures. These data suggest that enhanced cell cycle activation of CML CD34+ cells, by either autocrine stimuli or via enhanced sensitivity to exogenous stimuli, may be partially responsible for the pronounced cellular expansion characteristic of CML.

AB - To investigate the mechanisms behind the leukaemic expansion of chronic myelogenous leukaemia (CML), we examined the cell cycle status and activation kinetics of purified subpopulations of CD34+ cells from normal and CML bone marrow (BM). Propidium iodide staining was used to assess cell cycle status of fresh cells or those stimulated with cytokines. Although the cell cycle status of fresh low-density cells from CML and normal BM was similar, a larger percentage of CIVIL CD34+ cells were cycling than those from normal BM. The HLA-DR-compartment of CML CD34+ cells, a fraction enriched for normal, non-leukaemic progenitors, contained a higher percentage of quiescent cells than the CD34+ HLA-DR+ fraction. When the activation of CD34+ cells was examined in response to SCF or IL-3 alone, or SCF+IL-3+IL-6, CML CD34+ cells exited G0/G1 more rapidly than normal CD34+ cells. Interestingly, although normal BM CD34+ cells failed to cycle in response to IL-6 alone, or in the absence of exogenous cytokines, 30% of CML cells cycled under these conditions. No differences in the degree of apoptosis were documented among CML and normal CD34+ cells in these cultures. These data suggest that enhanced cell cycle activation of CML CD34+ cells, by either autocrine stimuli or via enhanced sensitivity to exogenous stimuli, may be partially responsible for the pronounced cellular expansion characteristic of CML.

KW - Apoptosis

KW - Cell cycle

KW - Chronic myelogenous leukaemia

KW - Cytokines

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=0031839844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031839844&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.1998.00839.x

DO - 10.1046/j.1365-2141.1998.00839.x

M3 - Article

VL - 102

SP - 759

EP - 767

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -